Table 3.
|
||||||
---|---|---|---|---|---|---|
Analysis Population | N | Eradicated
|
95% CI for Percent Eradicated | Difference from Standard Arm | Adjusted 95% CI for Difference | |
N | Percent | |||||
Intention to Treat (ITT) | 1463 | |||||
| ||||||
14-day Standard | 488 | 401 | 82.2% | 78.5%, 85.5% | (referent) | |
5-day Concomitant | 489 | 360 | 73.6% | 69.5%, 77.5% | 8.6% | 2.6%, 14.5% |
10-day Sequential | 486 | 372 | 76.5% | 72.5%, 80.2% | 5.6% | −0.4%, 11.6% |
| ||||||
Definitive 6-week UBT | 1414 | |||||
| ||||||
14-day Standard | 475 | 401 | 84.4% | 80.8%, 87.6% | (referent) | |
5-day Concomitant | 471 | 360 | 76.4% | 72.3%, 80.2% | 8.0% | 2.2%, 13.7% |
10-day Sequential | 468 | 372 | 79.4% | 75.5%, 83.1% | 4.9% | −0.9%, 10.8% |
| ||||||
Adherent to Therapy | 1314 | |||||
| ||||||
14-day Standard | 434 | 378 | 87.1% | 83.6%, 90.1% | (referent) | |
5-day Concomitant | 442 | 348 | 78.7% | 74.6%, 82.5% | 8.4% | 2.7%, 14.0% |
10-day Sequential | 438 | 355 | 81.1% | 77.1%, 84.6% | 6.0% | 0.3%, 11.8% |